Similar articles for PMID: 19761558

Year	Number of Results
1904	1
1969	1
1976	3
1984	1
1987	1
1989	2
1990	1
1991	1
1992	1
1993	2
1994	2
1995	14
1996	13
1997	12
1998	12
1999	13
2000	12
2001	16
2002	9
2003	15
2004	8
2005	15
2006	9
2007	13
2008	6
2009	12
2010	21
2011	30
2012	34
2013	37
2014	13
2015	14
2016	15
2017	20
2018	18
2019	22
2020	21
2021	15
2022	12
2023	3
2024	0

1

A multi-drug regimen for respiratory syncytial virus and parainfluenza virus infections in adult lung and heart-lung transplant recipients.

Liu V, Dhillon GS, Weill D. Liu V, et al. Transpl Infect Dis. 2010 Feb;12(1):38-44. doi: 10.1111/j.1399-3062.2009.00453.x. Epub 2009 Sep 15. Transpl Infect Dis. 2010. PMID: 19761558

2

Intravenous ribavirin is a safe and cost-effective treatment for respiratory syncytial virus infection after lung transplantation.

Glanville AR, Scott AI, Morton JM, Aboyoun CL, Plit ML, Carter IW, Malouf MA. Glanville AR, et al. J Heart Lung Transplant. 2005 Dec;24(12):2114-9. doi: 10.1016/j.healun.2005.06.027. Epub 2005 Sep 6. J Heart Lung Transplant. 2005. PMID: 16364859 Clinical Trial.

3

Respiratory syncytial virus and parainfluenza virus infections in the immunocompromised host.

Wendt CH, Hertz MI. Wendt CH, et al. Semin Respir Infect. 1995 Dec;10(4):224-31. Semin Respir Infect. 1995. PMID: 8668850 Review.

4

Intravenous palivizumab and ribavirin combination for respiratory syncytial virus disease in high-risk pediatric patients.

Chávez-Bueno S, Mejías A, Merryman RA, Ahmad N, Jafri HS, Ramilo O. Chávez-Bueno S, et al. Pediatr Infect Dis J. 2007 Dec;26(12):1089-93. doi: 10.1097/INF.0b013e3181343b7e. Pediatr Infect Dis J. 2007. PMID: 18043443

5

Paramyxovirus infection in lung transplant recipients.

Wendt CH, Fox JM, Hertz MI. Wendt CH, et al. J Heart Lung Transplant. 1995 May-Jun;14(3):479-85. J Heart Lung Transplant. 1995. PMID: 7654733

6

Oral versus inhaled ribavirin therapy for respiratory syncytial virus infection after lung transplantation.

Li L, Avery R, Budev M, Mossad S, Danziger-Isakov L. Li L, et al. J Heart Lung Transplant. 2012 Aug;31(8):839-44. doi: 10.1016/j.healun.2012.04.002. Epub 2012 May 22. J Heart Lung Transplant. 2012. PMID: 22621746

7

Pre-emptive oral ribavirin therapy of paramyxovirus infections after haematopoietic stem cell transplantation: a pilot study.

Chakrabarti S, Collingham KE, Holder K, Fegan CD, Osman H, Milligan DW. Chakrabarti S, et al. Bone Marrow Transplant. 2001 Oct;28(8):759-63. doi: 10.1038/sj.bmt.1703216. Bone Marrow Transplant. 2001. PMID: 11781627

8

Prophylaxis and treatment of respiratory syncytial virus in adult immunocompromised patients.

Hynicka LM, Ensor CR. Hynicka LM, et al. Ann Pharmacother. 2012 Apr;46(4):558-66. doi: 10.1345/aph.1Q553. Epub 2012 Mar 6. Ann Pharmacother. 2012. PMID: 22395247 Review.

9

Clinical features and outcomes of paramyxoviral infection in lung transplant recipients treated with ribavirin.

McCurdy LH, Milstone A, Dummer S. McCurdy LH, et al. J Heart Lung Transplant. 2003 Jul;22(7):745-53. doi: 10.1016/s1053-2498(02)00569-7. J Heart Lung Transplant. 2003. PMID: 12873542

10

Combination therapy with aerosolized ribavirin and intravenous immunoglobulin for respiratory syncytial virus disease in adult bone marrow transplant recipients.

Whimbey E, Champlin RE, Englund JA, Mirza NQ, Piedra PA, Goodrich JM, Przepiorka D, Luna MA, Morice RC, Neumann JL, et al. Whimbey E, et al. Bone Marrow Transplant. 1995 Sep;16(3):393-9. Bone Marrow Transplant. 1995. PMID: 8535312 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

432 results

Results by year